InMed Pharmaceuticals Inc. (INM)
USD 1.81
(-14.9%)
USD 1.81
(-14.9%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 644.86 Million USD | 0.0% |
| 2023 | 15.99 Thousand USD | -95.89% |
| 2022 | 389.49 Thousand USD | 105.77% |
| 2021 | 189.28 Thousand USD | -23.51% |
| 2020 | 247.46 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 14.2 Thousand CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | -100.0% |
| 2005 | 7512.41 CAD | -71.23% |
| 2004 | 26.11 Thousand CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 802.78 Thousand USD | 0.0% |
| 2024 Q4 | 644.86 Million USD | 0.0% |
| 2024 Q3 | 725.23 Thousand USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | 183.9 Thousand USD | -37.52% |
| 2023 Q4 | 15.99 Thousand USD | -78.03% |
| 2023 FY | 15.99 Thousand USD | -95.89% |
| 2023 Q3 | 72.79 Thousand USD | -60.42% |
| 2023 Q1 | 294.33 Thousand USD | -24.43% |
| 2022 Q3 | 493.56 Thousand USD | -17.55% |
| 2022 Q4 | 389.49 Thousand USD | -21.08% |
| 2022 FY | 389.49 Thousand USD | 105.77% |
| 2022 Q1 | 178.59 Thousand USD | -5.65% |
| 2022 Q2 | 598.64 Thousand USD | 235.2% |
| 2021 Q4 | 189.28 Thousand USD | -12.46% |
| 2021 Q1 | 235.59 Thousand CAD | -4.8% |
| 2021 Q3 | 216.23 Thousand USD | -9.52% |
| 2021 FY | 189.28 Thousand USD | -23.51% |
| 2021 Q2 | 238.99 Thousand USD | 1.44% |
| 2020 Q1 | 309.5 Thousand CAD | 0.0% |
| 2020 Q4 | 247.46 Thousand CAD | -3.66% |
| 2020 Q3 | 256.87 Thousand CAD | -13.12% |
| 2020 Q2 | 295.66 Thousand CAD | -4.47% |
| 2020 FY | 247.46 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | -100.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q2 | - CAD | -100.0% |
| 2009 Q1 | 8218.40 CAD | -42.15% |
| 2008 Q2 | 16.26 Thousand CAD | 0.0% |
| 2008 Q3 | 10.85 Thousand CAD | -33.28% |
| 2008 Q4 | 14.2 Thousand CAD | 30.88% |
| 2008 FY | 14.2 Thousand CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2006 Q3 | 4288.90 CAD | -16.98% |
| 2006 FY | - CAD | -100.0% |
| 2006 Q2 | 5166.18 CAD | 0.11% |
| 2006 Q1 | 5160.62 CAD | -31.31% |
| 2006 Q4 | - CAD | -100.0% |
| 2005 Q2 | 23.72 Thousand CAD | 4.91% |
| 2005 Q3 | 830.05 Thousand CAD | 3398.66% |
| 2005 Q4 | 7512.41 CAD | -99.09% |
| 2005 FY | 7512.41 CAD | -71.23% |
| 2005 Q1 | 22.61 Thousand CAD | -13.39% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q4 | 26.11 Thousand CAD | 0.0% |
| 2004 FY | 26.11 Thousand CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -805.43% |
| Alkermes plc | 287.73 Million USD | -124.122% |
| Agenus Inc. | 137.32 Million USD | -369.594% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 72.477% |
| Aptorum Group Limited | 3.05 Million USD | -20984.355% |
| Ardelyx, Inc. | 51.54 Million USD | -1151.023% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -516.459% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1508.945% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -541.032% |
| ChromaDex Corporation | 2.57 Million USD | -24943.301% |
| Chimerix, Inc. | 125 Thousand USD | -515792.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -19811.654% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2389.057% |
| CRISPR Therapeutics AG | 223 Million USD | -189.168% |
| Precision BioSciences, Inc. | 7.72 Million USD | -8249.929% |
| Dyadic International, Inc. | 88.87 Thousand USD | -725527.321% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -2931104.545% |
| Fortress Biotech, Inc. | 60.85 Million USD | -959.657% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1048529.179% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -16865.667% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -715430.824% |
| Incyte Corporation | 29.16 Million USD | -2111.32% |
| IO Biotech, Inc. | 1.83 Million USD | -34966.069% |
| Jaguar Health, Inc. | 30.99 Million USD | -1980.68% |
| Novavax, Inc. | 168.01 Million USD | -283.812% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -2700.717% |
| Opthea Limited | 200.53 Million USD | -221.571% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -11105.3% |
| ContextLogic Inc. | 6 Million USD | -10647.75% |
| MiMedx Group, Inc. | 48.09 Million USD | -1240.704% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -3108.443% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1684016.372% |
| NextCure, Inc. | 5.94 Million USD | -10739.889% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -444634.483% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -2816.49% |
| PDS Biotechnology Corporation | 19.5 Million USD | -3205.952% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -458.421% |
| Pharming Group N.V. | 166.1 Million USD | -288.227% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -10279.285% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1824.109% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -53371.393% |
| Acelyrin, Inc. | 1.19 Million USD | -53908.794% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -140088.043% |
| Summit Therapeutics Inc. | 103.29 Million USD | -524.325% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -17009.711% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1822.789% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -13410.685% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1766.145% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -969.056% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -40974.204% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2438.439% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -518.054% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -87996.311% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -5662.354% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -366.266% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -4698.46% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -4199.1% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -237.746% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1124.629% |
| Fortress Biotech, Inc. | 60.85 Million USD | -959.657% |
| Precigen, Inc. | 5.89 Million USD | -10839.186% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1435.832% |
| AlloVir, Inc. | 16.64 Million USD | -3773.528% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -880.679% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -562.351% |
| ImmuCell Corporation | 10.54 Million USD | -6017.976% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -57221.333% |
| Onconetix, Inc. | 118.85 Thousand USD | -542455.34% |
| PureTech Health plc | 18.25 Million USD | -3433.507% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -651278.788% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2039.778% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -2383.689% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1404.093% |
| Innoviva, Inc. | 446.23 Million USD | -44.513% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -77314.766% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -964631.315% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -211.577% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -805.76% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -20127.886% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -62025.723% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2788.404% |
| Aptose Biosciences Inc. | 621 Thousand USD | -103742.995% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -63689.031% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1282.11% |
| Kura Oncology, Inc. | 9.33 Million USD | -6810.255% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2315.225% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -467193.478% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -6771.231% |
| Autolus Therapeutics plc | 47.91 Million USD | -1245.88% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -13044.415% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -9421.113% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -393.544% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -7856.385% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1759.901% |
| INmune Bio, Inc. | 397 Thousand USD | -162334.509% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -271.139% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -15805.862% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -438735.923% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1195.638% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1081.721% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1311.299% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -36.229% |
| Verastem, Inc. | 40.08 Million USD | -1508.704% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -14549.364% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -6314.014% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -9728.761% |
| Histogen Inc. | 4.38 Million USD | -14609.512% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -73013.946% |
| Organovo Holdings, Inc. | 888 Thousand USD | -72519.932% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -2049.55% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -15275.894% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3312.887% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -751.869% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -692528.673% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2389.154% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -241422.472% |
| Amarin Corporation plc | 8.73 Million USD | -7280.852% |
| Mesoblast Limited | 100.48 Million USD | -541.765% |
| Turnstone Biologics Corp. | 1.18 Million USD | -54135.913% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -723.277% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -591519.266% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -686.334% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -239.503% |
| Better Therapeutics, Inc. | 10.34 Million USD | -6131.784% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -2688.605% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -593.157% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -49812.152% |
| Gritstone bio, Inc. | 40.14 Million USD | -1506.38% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -35449.338% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -319.853% |
| Insmed Incorporated | 1.19 Billion USD | 45.962% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -10055.354% |
| OmniAb, Inc. | 22.07 Million USD | -2821.246% |
| Alector, Inc. | 30.45 Million USD | -2017.366% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -535.06% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -7913.732% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -51.166% |
| Aura Biosciences, Inc. | 16.87 Million USD | -3722.555% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1033.45% |
| Immunic, Inc. | 639 Thousand USD | -100817.84% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -2062.598% |
| Veracyte, Inc. | 7.52 Million USD | -8469.635% |
| FibroGen, Inc. | 89.69 Million USD | -618.937% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -14768.919% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -492678.708% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 87.375% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1742778.378% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -32468.939% |
| TG Therapeutics, Inc. | 100.11 Million USD | -544.105% |
| Galecto, Inc. | 66 Thousand USD | -976968.182% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -474065.441% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 60.496% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -10620.948% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11848.583% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -35449.338% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -2906.784% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1664.095% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -124632.108% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1325.557% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -2009.194% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1339.367% |
| Vaxxinity, Inc. | 13.26 Million USD | -4762.502% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 20.511% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -143505.543% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -7237.183% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 76.142% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -203971.203% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -14365.343% |
| Ainos, Inc. | 5.92 Million USD | -10790.128% |
| Pluri Inc. | 29.05 Million USD | -2119.616% |
| Prothena Corporation plc | 10.72 Million USD | -5914.971% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -3148.527% |
| Celularity Inc. | 26.17 Million USD | -2363.479% |
| Rallybio Corporation | 173 Thousand USD | -372654.335% |
| Cue Biopharma, Inc. | 4.2 Million USD | -15246.621% |
| MeiraGTx Holdings plc | 72.11 Million USD | -794.168% |
| Omeros Corporation | 329.7 Million USD | -95.588% |
| Humacyte, Inc. | 38.6 Million USD | -1570.635% |
| Immunocore Holdings plc | 82.64 Million USD | -680.293% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -39879.231% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -17928.096% |
| Blueprint Medicines Corporation | 610.96 Million USD | -5.549% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -44129.424% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -577.457% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1224.593% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -609.415% |
| Pulmatrix, Inc. | 8.32 Million USD | -7644.266% |
| Elicio Therapeutics, Inc. | 6 Million USD | -10635.226% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -4881.576% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -566.548% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -137397.868% |
| Cytokinetics, Incorporated | 607.37 Million USD | -6.173% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -7319.064% |
| Nutriband Inc. | 79.82 Thousand USD | -807738.298% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -14281.467% |
| Vor Biopharma Inc. | 31.83 Million USD | -1925.966% |
| Roivant Sciences Ltd. | 477.85 Million USD | -34.95% |
| Evogene Ltd. | 10.65 Million USD | -5953.365% |
| ProKidney Corp. | 3.61 Million USD | -17763.296% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -84862.451% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2449436.58% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 62.847% |
| CorMedix Inc. | 517.01 Thousand USD | -124628.972% |
| BioLineRx Ltd. | 6.62 Million USD | -9629.406% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1650.543% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -798.879% |
| Atai Life Sciences N.V. | 15.21 Million USD | -4139.465% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -76451.926% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -252788.235% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1394.473% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -156931.364% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -47004.821% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -97150.184% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -262.141% |
| Biomea Fusion, Inc. | 7.83 Million USD | -8135.824% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -126.895% |
| Mereo BioPharma Group plc | 5.3 Million USD | -12067.264% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -29893.721% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -109570.918% |
| Absci Corporation | 4.66 Million USD | -13738.305% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -5496.815% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2741.441% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -6345.427% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -5505.085% |
| Allakos Inc. | 38.21 Million USD | -1587.466% |
| Imunon, Inc. | 1.13 Million USD | -56502.209% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -7373.23% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -77036.962% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -6448550.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -629.931% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -13594.309% |
| XOMA Corporation | 118.51 Million USD | -444.107% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -6304.459% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1639.165% |
| aTyr Pharma, Inc. | 13.76 Million USD | -4584.136% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -8063.882% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2483.18% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -3091.611% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -4299000.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -231707.398% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4361.234% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 56.987% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -473463.041% |
| UroGen Pharma Ltd. | 98.55 Million USD | -554.346% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -332.464% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -3282.1% |
| Entera Bio Ltd. | 256 Thousand USD | -251800.391% |
| GH Research PLC | 631 Thousand USD | -102097.306% |
| Lisata Therapeutics, Inc. | 137.00 USD | -470704279.562% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -100346.262% |
| Xencor, Inc. | 14.64 Million USD | -4304.214% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -429091.819% |
| Replimune Group, Inc. | 71.99 Million USD | -795.77% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -429810.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -9104.468% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -473463.041% |
| Portage Biotech Inc. | 7000.00 USD | -9212257.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -97150.184% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -45027.012% |
| OncoCyte Corporation | 2.2 Million USD | -29158.848% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -963751.73% |
| Purple Biotech Ltd. | 163 Thousand USD | -395522.699% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -25338.462% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1561.552% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -2454.528% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -883276.712% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -34701.133% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2347.491% |
| Curis, Inc. | 1.48 Million USD | -43208.596% |
| Daré Bioscience, Inc. | 3.91 Million USD | -16377.22% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -92325.274% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -10747650.0% |
| BeiGene, Ltd. | 197.61 Million USD | -226.319% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -70647.669% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -700.329% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1142.778% |
| bluebird bio, Inc. | 224.41 Million USD | -187.349% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -8.729% |
| DBV Technologies S.A. | 4.52 Million USD | -14148.011% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -48024.254% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -6519.431% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -17018.795% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -70.932% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1403.988% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -37457.659% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -69389.763% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -3591.905% |
| MacroGenics, Inc. | 30.19 Million USD | -2035.597% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -3542.688% |
| Prime Medicine, Inc. | 4.35 Million USD | -14700.666% |
| Aditxt, Inc. | 1.04 Million USD | -61802.444% |
| Adagene Inc. | 13.54 Million USD | -4662.654% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4594.366% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -24.322% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -3672.685% |
| SciSparc Ltd. | 24 Thousand USD | -2686837.5% |
| Vericel Corporation | 81.85 Million USD | -687.804% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -686.259% |
| Generation Bio Co. | 89.77 Million USD | -618.32% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2806.761% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -219.558% |
| Invivyd, Inc. | 722 Thousand USD | -89216.482% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1229.564% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -22056143.224% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -16759.216% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2803660.87% |
| 2seventy bio, Inc. | 244.01 Million USD | -164.275% |
| ADMA Biologics, Inc. | 130.59 Million USD | -393.794% |
| Clene Inc. | 7.15 Million USD | -8916.569% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -18999.986% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -160.428% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -58470.845% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -245221.743% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -234.786% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -2170.412% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -6590.165% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -477.458% |
| Evaxion Biotech A/S | 8.48 Million USD | -7496.702% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -760.681% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -896.469% |
| Trevena, Inc. | 35.23 Million USD | -1730.287% |
| Surrozen, Inc. | 882 Thousand USD | -73013.946% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -10274.276% |
| Cingulate Inc. | 135.09 Thousand USD | -477227.737% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2639.56% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1249.09% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -358158.333% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -2440.939% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -3598.257% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -68795.833% |
| Statera Biopharma, Inc. | 11.43 Million USD | -5541.301% |
| ImmunityBio, Inc. | 836.95 Million USD | 22.951% |
| Korro Bio, Inc. | 31.21 Million USD | -1965.816% |
| Kineta, Inc. | 150 Thousand USD | -429810.0% |
| BioVie Inc. | 349.89 Thousand USD | -184202.96% |
| Codexis, Inc. | 12.24 Million USD | -5167.214% |
| Celularity Inc. | 26.17 Million USD | -2363.479% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1256.04% |
| Celcuity Inc. | 37.03 Million USD | -1641.212% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -365583.745% |
| Cibus, Inc. | 17.67 Million USD | -3548.665% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -18984.492% |
| Kodiak Sciences Inc. | 100 Million USD | -544.865% |
| Annexon, Inc. | 29.19 Million USD | -2109.198% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -897.826% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -57374.599% |
| Avalo Therapeutics, Inc. | 2 Million USD | -32143.25% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 53.951% |
| Eyenovia, Inc. | 8.95 Million USD | -7099.379% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -882.143% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -7820.228% |
| Arcellx, Inc. | 50.84 Million USD | -1168.396% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -44129.424% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -2936.373% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -61024.645% |
| Moolec Science SA | 99.04 Thousand USD | -650976.268% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2234.691% |
| Geron Corporation | 35.05 Million USD | -1739.791% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -109014.213% |
| Royalty Pharma plc | 6.13 Billion USD | 89.489% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -39173.143% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -2031482.761% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -2685.835% |
| Humacyte, Inc. | 38.6 Million USD | -1570.635% |
| Structure Therapeutics Inc. | 4.01 Million USD | -15969.399% |
| 89bio, Inc. | 24.79 Million USD | -2500.786% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -5086.304% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -34458.682% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -62386.919% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -548.053% |
| Notable Labs, Ltd. | 1.52 Million USD | -42158.519% |
| Liquidia Corporation | 2.36 Million USD | -27178.553% |
| Mustang Bio, Inc. | 1.97 Million USD | -32501.871% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4594.366% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -9174.63% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -203327.445% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1192.911% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -6614.546% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -984592.086% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -474065.441% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -10194.78% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -495950.0% |
| PepGen Inc. | 17.1 Million USD | -3671.14% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -135947.468% |
| United Therapeutics Corporation | 300 Million USD | -114.955% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -2593.559% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -15390.942% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -111468.339% |
| XOMA Corporation | 118.51 Million USD | -444.107% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1742778.378% |
| Bionomics Limited | 117.62 Million USD | -448.224% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -69017.363% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -11394.92% |
| uniQure N.V. | 130.06 Million USD | -395.802% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1000.64% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -93903.644% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -14768.919% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -46460.65% |
| Altimmune, Inc. | 175 Thousand USD | -368394.286% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -66.263% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -11394.92% |
| Compugen Ltd. | 719 Thousand USD | -89589.152% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -12629.274% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -662.657% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -6394.109% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -10009.186% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -605.464% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -6394.109% |
| Instil Bio, Inc. | 81.42 Million USD | -691.955% |
| argenx SE | 15.35 Million USD | -4099.98% |
| Immunome, Inc. | 1.34 Million USD | -48024.254% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -120210.634% |
| Verona Pharma plc | 48.37 Million USD | -1233.082% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -6897.233% |
| Shattuck Labs, Inc. | 3.4 Million USD | -18833.206% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -758564.706% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -383748.214% |
| Moolec Science SA | 99.04 Thousand USD | -650976.268% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -5745.369% |
| AnaptysBio, Inc. | 16.03 Million USD | -3921.107% |
| Design Therapeutics, Inc. | 2.33 Million USD | -27529.177% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2382024.783% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -10647.75% |
| Achilles Therapeutics plc | 1.07 Million USD | -59831.691% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -6897.233% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -3234575.963% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -3751.681% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -807738.298% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -8643044.351% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -4960400.0% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -88.292% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2533.822% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -25694.703% |
| Palisade Bio, Inc. | 90 Thousand USD | -716416.667% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -332304.639% |
| Beam Therapeutics Inc. | 159.91 Million USD | -303.265% |
| Neurogene Inc. | 13.37 Million USD | -4722.142% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -110.451% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2355.413% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1077872.987% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -64386.5% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1491.945% |
| Athira Pharma, Inc. | 1.21 Million USD | -52888.085% |
| Vaccinex, Inc. | 26 Thousand USD | -2480150.0% |
| HCW Biologics Inc. | 6.3 Million USD | -10128.941% |
| XOMA Corporation | 118.51 Million USD | -444.107% |
| Nektar Therapeutics | 112.62 Million USD | -472.577% |
| Arvinas, Inc. | 800 Thousand USD | -80508.125% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4361.234% |
| Merus N.V. | 10.48 Million USD | -6048.598% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -4232.314% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -4702.033% |
| Rezolute, Inc. | 1.66 Million USD | -38747.289% |
| Clene Inc. | 7.15 Million USD | -8916.569% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -879085.527% |
| BeyondSpring Inc. | 3.36 Million USD | -19069.59% |
| Synlogic, Inc. | 12.49 Million USD | -5062.637% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1874.721% |
| Krystal Biotech, Inc. | 6.62 Million USD | -9641.163% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -277.293% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -10654.92% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1361207.551% |
| MannKind Corporation | 252.15 Million USD | -155.746% |
| Ikena Oncology, Inc. | 7.18 Million USD | -8881.407% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -323952.764% |
| Gossamer Bio, Inc. | 197.4 Million USD | -226.671% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -123912.5% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -129.222% |
| Mural Oncology plc | 8.91 Million USD | -7136.73% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -1374.449% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -44807.033% |
| Champions Oncology, Inc. | 6.09 Million USD | -10483.703% |
| REGENXBIO Inc. | 82.22 Million USD | -684.297% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -130438.681% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -14443.64% |
| Vaxart, Inc. | 2.62 Million USD | -24485.017% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -237304.788% |
| Cellectis S.A. | 36.24 Million USD | -1679.38% |
| Longeveron Inc. | 1.44 Million USD | -44434.876% |
| Repare Therapeutics Inc. | 1.01 Million USD | -63748.02% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 43.059% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1340.428% |
| Revolution Medicines, Inc. | 80.57 Million USD | -700.329% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -20001.777% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -364230.508% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -524180.488% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 11.016% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1333.639% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -5057.167% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -477227.737% |
| Passage Bio, Inc. | 22.92 Million USD | -2713.424% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -10578.341% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -99570.015% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -3097.942% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -131505.102% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -158165.78% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -54181.566% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -138283.047% |
| OmniAb, Inc. | 22.07 Million USD | -2821.246% |
| Anew Medical, Inc. | 1.54 Million USD | -41774.351% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -2081.547% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -7038.99% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1974.188% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -15805.862% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1150.781% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -10028.239% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4464.123% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -95862.054% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1989.647% |
| Equillium, Inc. | 384 Thousand USD | -167833.594% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -10370.287% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -326.924% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -1219.309% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -535938.47% |
| Dominari Holdings Inc. | 3.02 Million USD | -21196.731% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -3261241.223% |
| vTv Therapeutics Inc. | 169 Thousand USD | -381476.923% |
| Bio-Techne Corporation | 319 Million USD | -102.152% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1031.58% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -261.135% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -4085.533% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -5107.664% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -13315.124% |
| Nkarta, Inc. | 82.27 Million USD | -683.84% |
| BioCardia, Inc. | 982 Thousand USD | -65568.534% |
| Iterum Therapeutics plc | 18.95 Million USD | -3301.904% |